BioCentury
ARTICLE | Clinical News

CM-24: Phase I started

May 18, 2015 7:00 AM UTC

cCam began an open-label, dose-escalation, international Phase I trial to evaluate IV CM-24 in about 62 patients with advanced or recurrent malignancies, including melanoma and bladder, colorectal, ga...